Caroline Kistorp

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes
    Caroline Kistorp
    Department of Endocrinology, Herlev University Hospital, Copenhagen, Denmark
    Eur J Heart Fail 10:380-7. 2008
  2. ncbi Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
    Caroline Kistorp
    Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark
    Circulation 112:1756-62. 2005
  3. ncbi N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
    Caroline Kistorp
    Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark
    JAMA 293:1609-16. 2005
  4. ncbi Prevalence and characteristics of diabetic patients in a chronic heart failure population
    Caroline Kistorp
    Department of Cardiology and Endocrinology, Copenhagen University Hospital, Frederiksberg, Denmark
    Int J Cardiol 100:281-7. 2005
  5. ncbi Plasma YKL-40 levels are elevated in patients with chronic heart failure
    Camilla Noelle Rathcke
    Department of Endocrinology, Copenhagen University Hospital Herlev, Denmark
    Scand Cardiovasc J 44:92-9. 2010
  6. ncbi α-Defensins and outcome in patients with chronic heart failure
    Heidi M Christensen
    Department of Cardiology, Herlev University Hospital, Herlev Ringvej 75, Herlev, Denmark
    Eur J Heart Fail 14:387-94. 2012
  7. ncbi Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population
    Mikkel Andreassen
    Department of Endocrinology, Herlev Hospital, University of Copenhagen, Denmark
    Inflamm Res 59:503-10. 2010
  8. ncbi Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population
    Camilla Noelle Rathcke
    Department of Endocrinology, Herlev Hospital, University of Copenhagen, Herlev, Denmark
    Int J Cardiol 143:35-42. 2010
  9. ncbi N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism
    Marianne Schultz
    Department of Cardiology and Endocrinology E, Frederiksberg University Hospital, Frederiksberg, Denmark
    Thyroid 17:237-41. 2007
  10. ncbi N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states
    Marianne Schultz
    Department of Cardiology and Endocrinology E, Frederiksberg University Hospital, Frederiksberg, Denmark
    Clin Endocrinol (Oxf) 60:54-9. 2004

Detail Information

Publications20

  1. ncbi Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes
    Caroline Kistorp
    Department of Endocrinology, Herlev University Hospital, Copenhagen, Denmark
    Eur J Heart Fail 10:380-7. 2008
    ..The impact of diabetes mellitus (DM) on these biomarkers, and their relation to prognosis remains unknown...
  2. ncbi Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
    Caroline Kistorp
    Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark
    Circulation 112:1756-62. 2005
    ..In a prospective study, we therefore evaluated the association between plasma adiponectin levels and mortality among patients with CHF...
  3. ncbi N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
    Caroline Kistorp
    Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark
    JAMA 293:1609-16. 2005
    ....
  4. ncbi Prevalence and characteristics of diabetic patients in a chronic heart failure population
    Caroline Kistorp
    Department of Cardiology and Endocrinology, Copenhagen University Hospital, Frederiksberg, Denmark
    Int J Cardiol 100:281-7. 2005
    ..A second aim was to characterize patients with DM with respect to severity of CHF...
  5. ncbi Plasma YKL-40 levels are elevated in patients with chronic heart failure
    Camilla Noelle Rathcke
    Department of Endocrinology, Copenhagen University Hospital Herlev, Denmark
    Scand Cardiovasc J 44:92-9. 2010
    ..We investigated plasma YKL-40 levels in patients with CHF and evaluated the possible predictive value with respect to overall mortality and recurrent cardiovascular outcomes...
  6. ncbi α-Defensins and outcome in patients with chronic heart failure
    Heidi M Christensen
    Department of Cardiology, Herlev University Hospital, Herlev Ringvej 75, Herlev, Denmark
    Eur J Heart Fail 14:387-94. 2012
    ....
  7. ncbi Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population
    Mikkel Andreassen
    Department of Endocrinology, Herlev Hospital, University of Copenhagen, Denmark
    Inflamm Res 59:503-10. 2010
    ..The objective of the present study was to test the hypothesis that circulating levels of insulin-like growth factor-I (IGF-I) are inversely associated with inflammatory processes in an elderly background population...
  8. ncbi Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population
    Camilla Noelle Rathcke
    Department of Endocrinology, Herlev Hospital, University of Copenhagen, Herlev, Denmark
    Int J Cardiol 143:35-42. 2010
    ..We aimed to investigate whether YKL-40 could predict overall and cardiovascular (CV) mortality in a 50+ years population without known CVD...
  9. ncbi N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism
    Marianne Schultz
    Department of Cardiology and Endocrinology E, Frederiksberg University Hospital, Frederiksberg, Denmark
    Thyroid 17:237-41. 2007
    ..Recent data suggest a direct stimulatory effect of thyroid hormones on NT-proBNP synthesis. We examined the influence of acutely induced hyperthyroidism on serum levels of NT-proBNP...
  10. ncbi N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states
    Marianne Schultz
    Department of Cardiology and Endocrinology E, Frederiksberg University Hospital, Frederiksberg, Denmark
    Clin Endocrinol (Oxf) 60:54-9. 2004
    ..CONCLUSIONS: Serum NT-pro-BNP levels are affected by thyroid function. This seems due to a direct stimulatory effect of thyroid hormones...
  11. ncbi N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events
    Frants Pedersen
    Department of Cardiology and Endocrinology, Copenhagen University Hospital, Frederiksberg, Denmark
    J Card Fail 11:S70-5. 2005
    ....
  12. ncbi Biochemical cardiac risk markers in the general population, hypertension and coronary artery disease
    Charlotte Kragelund
    Frederiksberg University Hospital, Frederiksberg, Denmark
    Scand J Clin Lab Invest Suppl 240:138-42. 2005
    ..Natriuretic peptides are useful when screening for heart failure in symptomatic individuals. However, the use of NT-proBNP screening for risk or left ventricular systolic dysfunction in the general population is still a matter of debate...
  13. ncbi Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure
    Pernille Corell
    Department of Cardiology and Endocrinology E, Frederiksberg University Hospital, Ndr Fasanvej 57, 2000 Frederiksberg, Denmark
    Int J Cardiol 117:395-402. 2007
    ..The aim of our study was to examine the levels of N-terminal pro brain natriuretic peptide (NT-proBNP) in patients with HF and AF versus HF and sinus rhythm (SR) and if NT-proBNP has prognostic influence in patients with AF...
  14. ncbi Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses
    Louise Balling
    Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
    J Card Fail 18:351-8. 2012
    ....
  15. ncbi IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population
    Mikkel Andreassen
    Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
    Eur J Endocrinol 160:25-31. 2009
    ..However, in animal models reduced GH-IGF1 signalling increases lifespan. Reduced IGF1 activity might also be associated with longevity in humans...
  16. ncbi Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism
    Christina Gerlach Ogard
    Department of Clinical Physiology, Herlev University Hospital, Denmark
    Clin Endocrinol (Oxf) 63:493-8. 2005
    ..Increased risk of cardiovascular disease has been reported in patients with primary hyperparathyroidism (PHPT). The aim of this study was to evaluate novel plasma risk markers of cardiovascular disease in patients with PHPT...
  17. ncbi Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study
    Aun Yeong Chong
    Haemostasis, Thrombosis and Vascular Biology Unit, City Hospital, Dudley Road, Birmingham, B18 7QH United Kingdom
    Int J Cardiol 119:80-2. 2007
    ....
  18. ncbi Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure
    Bethan Freestone
    Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK
    Chest 133:1203-8. 2008
    ..It is unknown whether AF influences the degree of endothelial dysfunction in patients with systolic HF...
  19. ncbi N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances
    Mikkel Andreassen
    Department of Endocrinology and Internal Medicine J106, Copenhagen University Hospital Herlev, Denmark
    Clin Endocrinol (Oxf) 66:619-25. 2007
    ..They are cardioprotective hormones that compensate heart disease by promoting natriuresis and modulation of cardiac hypertrophy in response to volume expansion and ventricular wall stretch...
  20. ncbi Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics?
    Caroline Kistorp
    Circulation 114:184-6. 2006